Stephen Spates, MD
Dermatology · Verona, NJNPI 1740251495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Johnson & Johnson at 27.3% of the total. 2025 is the largest year on record at $708, 3.5 times the $200 reported in 2019. That places this record below the midpoint for dermatology clinicians in NJ, where the typical reported total is $1,986.
Across 188 payments — averaging $13.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$677
- Sun Pharmaceutical Industries Inc.$325
- Convatec Inc.$183
- Amgen$157
- AbbVie$141
- Incyte Corporation$140
- plus $856 from 22 others
What the payments were for
- Food & beverage$2,478100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 46 | $677 |
| Sun Pharmaceutical Industries Inc. | 49 | $325 |
| Convatec Inc. | 10 | $183 |
| Amgen | 10 | $157 |
| AbbVie | 8 | $141 |
| Incyte Corporation | 9 | $140 |
| Lilly USA, LLC | 7 | $106 |
| Mayne Pharma Commercial LLC | 8 | $89 |
| UCB, Inc. | 5 | $82 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $78 |
| Sanofi | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Galderma Laboratories, L.p. | 3 | $46 |
| Almirall LLC | 3 | $45 |
| Novartis | 1 | $35 |
| Genentech USA, Inc. | 2 | $30 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $27 |
| EPI Health, LLC | 1 | $27 |
| Biofrontera Inc. | 2 | $26 |
| Organogenesis Inc. | 1 | $22 |
| Botanix SB Inc | 1 | $18 |
| Mission Pharmacal Company | 1 | $16 |
| LEO Pharma Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
| Dermira, Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Merck | 1 | $14 |
| Journey Medical Corporation | 1 | $13 |
How this compares
$2,478 in reported general payments places this provider in the 50th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 269 | $5,918 |
| Mupirocin | 743 | $5,128 |
| Doxycycline Monohydrate | 70 | $675 |
| Amoxicillin | 46 | $79 |
| Cephalexin | 18 | $48 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Verona
- Daniel GroisserVerona$71K
- Justin BrownVerona$21K
- Karen GordonVerona$19K
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Ronald BernardinVoorhees$688K
- Brian MachlerFlorham Park$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.